These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 27769613)

  • 1. Acute intoxication caused by three common synthetic cannabinoids: The experience of a large, urban, tertiary care hospital.
    Shopan N; Scolnik D; Hassoun E; Firsow A; Volkov I; Glatstein M
    Am J Emerg Med; 2023 Nov; 73():7-10. PubMed ID: 37572408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unknown origin of acute myocardial infarction and lifesaving percutaneous coronary intervention in a 10-year-old girl.
    Temel MT; Altunbaş G; Başpınar O
    Ann Pediatr Cardiol; 2022; 15(4):419-421. PubMed ID: 36935834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
    Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
    Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies.
    Canazza I; Ossato A; Vincenzi F; Gregori A; Di Rosa F; Nigro F; Rimessi A; Pinton P; Varani K; Borea PA; Marti M
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28597570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York.
    Adams AJ; Banister SD; Irizarry L; Trecki J; Schwartz M; Gerona R
    N Engl J Med; 2017 Jan; 376(3):235-242. PubMed ID: 27973993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic effects of AB-CHMINACA on liver and kidney and detection of its blood level in adult male mice.
    Mohammad SA; Mousa REA; Gebril SM; Masoud KMM; Radwan RA
    Forensic Toxicol; 2024 Jan; 42(1):7-17. PubMed ID: 37573525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.
    Mohr ALA; Logan BK; Fogarty MF; Krotulski AJ; Papsun DM; Kacinko SL; Huestis MA; Ropero-Miller JD
    J Anal Toxicol; 2022 Jul; 46(6):e116-e185. PubMed ID: 35445267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of synthetic cannabinoids on the cardiovascular system: A case-control study.
    Yeniocak S; Kalkan A; Yamanoğlu A; Öztürk S; Söğüt Ö; Metiner M
    Turk J Emerg Med; 2021; 21(4):198-204. PubMed ID: 34849432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications.
    Lobato-Freitas C; Brito-da-Costa AM; Dinis-Oliveira RJ; Carmo H; Carvalho F; Silva JP; Dias-da-Silva D
    Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33669071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Literature Review of Cannabis and Myocardial Infarction-What Clinicians May Not Be Aware Of.
    Chetty K; Lavoie A; Deghani P
    CJC Open; 2021 Jan; 3(1):12-21. PubMed ID: 33458628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of atorvastatin and ticagrelor combination therapy on renal function and the levels of suppression of tumorigenicity 2 and interleukin-33 in patients with ST-segment elevation myocardial infarction.
    Zhang L; Hu M; Chen Y; Wang Y
    J Int Med Res; 2020 Dec; 48(12):300060520959502. PubMed ID: 33275460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An outbreak of deaths associated with AMB-FUBINACA in Auckland NZ.
    Morrow PL; Stables S; Kesha K; Tse R; Kappatos D; Pandey R; Russell S; Linsell O; McCarthy MJ; Spark A; Vertes D; Triggs Y; McCarthy S; Cuthers N; Massey R
    EClinicalMedicine; 2020 Aug; 25():100460. PubMed ID: 32743487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designer drugs: mechanism of action and adverse effects.
    Luethi D; Liechti ME
    Arch Toxicol; 2020 Apr; 94(4):1085-1133. PubMed ID: 32249347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA.
    Finlay DB; Manning JJ; Ibsen MS; Macdonald CE; Patel M; Javitch JA; Banister SD; Glass M
    ACS Chem Neurosci; 2019 Oct; 10(10):4350-4360. PubMed ID: 31513380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute carotid thrombosis and ischemic stroke following overdose of the synthetic cannabinoid K2 in a previously healthy young adult male.
    Faroqui R; Mena P; Wolfe AR; Bibawy J; Visvikis GA; Mantello MT
    Radiol Case Rep; 2018 Jun; 13(3):747-752. PubMed ID: 30167028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speckle-tracking strain assessment of left ventricular dysfunction in synthetic cannabinoid and heroin users.
    Demirkıran A; Albayrak N; Albayrak Y; Zorkun CS
    Anatol J Cardiol; 2018 Jun; 19(6):388-393. PubMed ID: 29848923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic Cannabinoid Abuse Resulting in ST-Segment Elevation Myocardial Infarction Requiring Percutaneous Coronary Intervention.
    Hamilton RJ; Keyfes V; Banka SS
    J Emerg Med; 2017 Apr; 52(4):496-498. PubMed ID: 27769613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of ST segment-elevated myocardial infarction with less common forms of single coronary artery.
    Koga M; Kawamura Y; Ito D; Iseki H; Ikari Y
    Cardiovasc Interv Ther; 2016 Oct; 31(4):304-8. PubMed ID: 26395004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA.
    Angerer V; Jacobi S; Franz F; Auwärter V; Pietsch J
    Forensic Sci Int; 2017 Dec; 281():e9-e15. PubMed ID: 29133010
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.